SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001387131-20-006373
Filing Date
2020-07-14
Accepted
2020-07-14 06:10:43
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS PURSUANT TO RULE 424(B)(5) tnxp-424b5_071320.htm 424B5 585721
2 GRAPHIC tnxp424b5022820001.jpg GRAPHIC 14725
  Complete submission text file 0001387131-20-006373.txt   607230
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-224586 | Film No.: 201026272
SIC: 2834 Pharmaceutical Preparations